SHANGHAI: A Chinese group led by drugmaker Shanghai Pharmaceuticals Holding Co Ltd and private equity firm Primavera Capital has agreed to buy Australian vitamins maker Vitaco Holdings for A$313.7mil (US$239mil).
Vitaco said in a statement that the Chinese group would buy all of the firm at a valuation of A$2.25 per share, a 28% premium to their closing price on Wednesday, less than a year after it listed shares in Sydney at A$2.10 apiece.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
